The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Assessing safety and activity of cabozantinib combined with lanreotide in gastroenteropancreatic (GEP) and thoracic neuroendocrine tumors (NETs): The phase II LOLA trial.
 
Francesca Corti
No Relationships to Disclose
 
Vito Amoroso
No Relationships to Disclose
 
Davide Campana
No Relationships to Disclose
 
Maria Pia Brizzi
No Relationships to Disclose
 
Francesco Panzuto
No Relationships to Disclose
 
Ivana Puliafito
No Relationships to Disclose
 
Natalie Prinzi
Honoraria - Ipsen; Italfarmaco; Novartis
Travel, Accommodations, Expenses - Ipsen; Italfarmaco; Novartis
 
Massimo Milione
No Relationships to Disclose
 
Monica Niger
Consulting or Advisory Role - EMD Serono
Travel, Accommodations, Expenses - Celgene
 
Maria Antista
No Relationships to Disclose
 
Alessandra Raimondi
No Relationships to Disclose
 
Federica Morano
Honoraria - SERVIER
Travel, Accommodations, Expenses - Sanofi; SERVIER
 
Michele Prisciandaro
No Relationships to Disclose
 
Teresa Beninato
No Relationships to Disclose
 
Filippo Pagani
No Relationships to Disclose
 
Giovanni Randon
No Relationships to Disclose
 
Iolanda Pulice
No Relationships to Disclose
 
Maria Di Bartolomeo
Honoraria - Lilly; MSD Oncology; SERVIER
Consulting or Advisory Role - Lilly; MSD Oncology
Research Funding - Lilly
Travel, Accommodations, Expenses - Roche; Sanofi
 
Filippo G. De Braud
Honoraria - BMS; Merck; MSD; Pfizer; Roche; Sanofi; SERVIER
Consulting or Advisory Role - Bristol-Myers Squibb; EMD SERONO; Incyte; Nerviano Medical Sciences; Novartis Italy; Roche; Sanofi; Teofarma
Research Funding - Kymab (Inst); Loxo (Inst); Merck Serono (Inst); Nerviano Medical Sciences (Inst); Novartis (Inst); Pfizer (Inst); Philogen (Inst); Roche (Inst); SERVIER (Inst); Tesaro (Inst)
 
Sara Pusceddu
Honoraria - Ipsen; Italfarmaco; Novartis; Pfizer
Consulting or Advisory Role - Ipsen; Novartis
Research Funding - Ipsen; Pfizer
Travel, Accommodations, Expenses - Ipsen